NaMESA Career Q&A – Dr. Russell Johnson (Scientist, PhaseRx)NaMESA Career Q&A – Dr. Russell Johnson (Scientist, PhaseRx)
MolES 215 (Molecular Engineering & Sciences building)
Tuesday, November 19, 2013
Dr. Russell Johnson is a Scientist at PhaseRx, Seattle-based company developing new RNAi-based therapeutics. Russell joined PhaseRx in a versatile capacity as a bioconjugate chemist to assist in the development of novel synthetic RNAi delivery vehicles and quickly became a strong contributing member of an interdisciplinary research team. He received his Ph.D. in Bioengineering from the University of Utah in 2009 and was a Senior Fellow in Pun research group at the University of Washington, Dept. of Bioengineering prior to joining PhaseRx in 2011.
Refreshments will be provided.